Ablink Biotech

Company Deals

HitGen Inc. Partners with Ablink Biotech to Develop Antibody-Oligonucleotide Conjugates

Fineline Cube Oct 10, 2024

China-based HitGen Inc. (SHA: 688222) has entered into a partnership with compatriot firm Ablink Biotech...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod